Immatics (IMTX) Divestments (2020 - 2024)

Immatics' (IMTX) quarterly Divestments came in at $73.6 million in Q3 2024, up 195.8% year-on-year from $24.9 million in Q4 2023, and up 195.8% quarter-over-quarter from -$76.8 million in Q3 2023.

Immatics (IMTX) Divestments (2020 - 2024) Analysis & Trends

Immatics has disclosed Divestments across 5 years of filings, most recently posting $73.6 million for Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Immatics 14.67 Bn 14.67 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 73.59 Mn
Sep 30, 2023 -76.82 Mn
Sep 30, 2022 -71.65 Bn
Jun 30, 2021 -15.49 Bn
Mar 31, 2021 3.09 Bn
Jun 30, 2020 33.81 Bn
Mar 31, 2020 -21.22 Bn